Sopharma AD (SPH.WA)
PLN 12.75
(0.0%)
PLN 12.75
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 757.08 Million BGN | 40.81% |
| 2022 | 537.66 Million BGN | -1.55% |
| 2021 | 546.11 Million BGN | -19.16% |
| 2020 | 675.51 Million BGN | 12.68% |
| 2019 | 599.5 Million BGN | 19.4% |
| 2018 | 502.07 Million BGN | 5.12% |
| 2017 | 477.62 Million BGN | 29.79% |
| 2016 | 367.99 Million BGN | -2.64% |
| 2015 | 377.98 Million BGN | -2.01% |
| 2014 | 385.72 Million BGN | 4.25% |
| 2013 | 370.01 Million BGN | 4.5% |
| 2012 | 354.06 Million BGN | 13.93% |
| 2011 | 310.77 Million BGN | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 662.26 Million BGN | -18.2% |
| 2024 Q1 | 809.65 Million BGN | 6.94% |
| 2023 Q2 | 637.67 Million BGN | 13.45% |
| 2023 Q1 | 562.05 Million BGN | 4.54% |
| 2023 Q4 | 757.08 Million BGN | 6.9% |
| 2023 Q3 | 708.18 Million BGN | 11.06% |
| 2023 FY | 757.08 Million BGN | 40.81% |
| 2022 Q3 | 531.76 Million BGN | 3.04% |
| 2022 Q4 | 537.66 Million BGN | 1.11% |
| 2022 FY | 537.66 Million BGN | -1.55% |
| 2022 Q1 | 519.33 Million BGN | -4.9% |
| 2022 Q2 | 516.05 Million BGN | -0.63% |
| 2021 Q3 | 615.24 Million BGN | -1.97% |
| 2021 FY | 546.11 Million BGN | -19.16% |
| 2021 Q2 | 627.62 Million BGN | -1.1% |
| 2021 Q4 | 546.11 Million BGN | -11.24% |
| 2021 Q1 | 634.63 Million BGN | -6.05% |
| 2020 Q3 | 607.22 Million BGN | 0.86% |
| 2020 Q1 | 629.04 Million BGN | 4.93% |
| 2020 Q2 | 602.01 Million BGN | -4.3% |
| 2020 FY | 675.51 Million BGN | 12.68% |
| 2020 Q4 | 675.51 Million BGN | 11.25% |
| 2019 Q1 | 581 Million BGN | 15.72% |
| 2019 FY | 599.5 Million BGN | 19.4% |
| 2019 Q4 | 599.5 Million BGN | -2.59% |
| 2019 Q3 | 615.41 Million BGN | 1.97% |
| 2019 Q2 | 603.55 Million BGN | 3.88% |
| 2018 Q3 | 491.1 Million BGN | 1.81% |
| 2018 Q4 | 502.07 Million BGN | 2.23% |
| 2018 FY | 502.07 Million BGN | 5.12% |
| 2018 Q1 | 470.98 Million BGN | -1.39% |
| 2018 Q2 | 482.37 Million BGN | 2.42% |
| 2017 Q1 | 348.91 Million BGN | -5.18% |
| 2017 Q3 | 434.79 Million BGN | 8.09% |
| 2017 FY | 477.62 Million BGN | 29.79% |
| 2017 Q4 | 477.62 Million BGN | 9.85% |
| 2017 Q2 | 402.26 Million BGN | 15.29% |
| 2016 Q4 | 367.99 Million BGN | -0.8% |
| 2016 Q2 | 368.87 Million BGN | -1.91% |
| 2016 FY | 367.99 Million BGN | -2.64% |
| 2016 Q3 | 370.96 Million BGN | 0.57% |
| 2016 Q1 | 376.05 Million BGN | -0.51% |
| 2015 Q1 | 400.53 Million BGN | 3.84% |
| 2015 Q4 | 377.98 Million BGN | -5.78% |
| 2015 Q3 | 401.18 Million BGN | 0.0% |
| 2015 Q2 | 401.17 Million BGN | 0.16% |
| 2015 FY | 377.98 Million BGN | -2.01% |
| 2014 Q4 | 385.72 Million BGN | -1.26% |
| 2014 FY | 385.72 Million BGN | 4.25% |
| 2014 Q1 | 369.1 Million BGN | -0.25% |
| 2014 Q3 | 390.64 Million BGN | 2.41% |
| 2014 Q2 | 381.44 Million BGN | 3.34% |
| 2013 Q1 | 378.79 Million BGN | 6.98% |
| 2013 Q2 | 384.1 Million BGN | 1.4% |
| 2013 Q3 | 371.99 Million BGN | -3.15% |
| 2013 Q4 | 370.01 Million BGN | -0.53% |
| 2013 FY | 370.01 Million BGN | 4.5% |
| 2012 Q3 | 352.81 Million BGN | 0.0% |
| 2012 FY | 354.06 Million BGN | 13.93% |
| 2012 Q4 | 354.06 Million BGN | 0.35% |
| 2011 FY | 310.77 Million BGN | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|